Literature DB >> 32122994

Cutting Edge: The Use of Topical Aminoglycosides as an Effective Pull in "Prime and Pull" Vaccine Strategy.

Smita Gopinath1,2, Peiwen Lu2, Akiko Iwasaki3,2,4.   

Abstract

The presence of tissue-resident memory T cells at barrier tissues is critical for long-lasting protective immune responses. Previous work has shown that tissue-resident memory T cells can be established by "pulling" virus-specific effector T cells from circulation to the genital mucosa via topical vaginal application of chemokines in mice. Once established, these cells protect hosts against genital herpes infection. We recently showed that vaginal application of aminoglycoside antibiotics induces robust activation of the IFN signaling pathway, including upregulation of chemokine expression within the tissue in mice. In this study, we show that a single topical application of neomycin, an inexpensive and vaginally nontoxic antibiotic, is sufficient to pull CD8 T cells to the vaginal mucosa and provide protection against genital herpes infection in mice.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32122994     DOI: 10.4049/jimmunol.1900462

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

Review 1.  Tissue-resident immunity in the female and male reproductive tract.

Authors:  Dennis Yüzen; Petra Clara Arck; Kristin Thiele
Journal:  Semin Immunopathol       Date:  2022-04-29       Impact factor: 11.759

Review 2.  Tissue-specific immunity for a changing world.

Authors:  Stuart P Weisberg; Basak B Ural; Donna L Farber
Journal:  Cell       Date:  2021-03-18       Impact factor: 41.582

Review 3.  The spatio-temporal control of effector T cell migration.

Authors:  Deborah J Fowell; Minsoo Kim
Journal:  Nat Rev Immunol       Date:  2021-02-24       Impact factor: 108.555

Review 4.  Inducing Immunity Where It Matters: Orthotopic HPV Tumor Models and Therapeutic Vaccinations.

Authors:  Samantha Zottnick; Alessa L Voß; Angelika B Riemer
Journal:  Front Immunol       Date:  2020-08-14       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.